Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Esperion Therapeutics Inc

+ Add to Watchlist

ESPR:US

97.0000 USD 6.8500 6.60%

As of 20:10:00 ET on 05/05/2015.

Snapshot for Esperion Therapeutics Inc (ESPR)

Open: 103.2400 Day's Range: 95.7800 - 103.8000 Volume: 739,928
Previous Close: 103.8500 52wk Range: 12.7730 - 118.9500 1-Yr Rtn: +643.87%

Stock Chart for ESPR

No chart data available.
  • ESPR:US 97.1048
  • 1D
  • 1M
  • 1Y
103.8500
Interactive ESPR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ESPR

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -2.2400
Est. EPS (USD) (12/2015) -2.2700
Est. PEG Ratio -
Market Cap (M USD) 2,176.52
Shares Outstanding (M) 22.44
30 Day Average Volume 971,895
Price/Book (mrq) 14.7753
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ESPR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ESPR

Esperion Therapeutics, Inc. develops and markets medical devices. The Company produces oral, small molecule therapies for the treatment of patients with elevated levels of low-density lipoprotein cholesterol and other cardio metabolic risk factors.

Roger S NewtonChairman/Chief Scientific Ofcr/Co-FounderTimothy M Mayleben "Tim"President/CEO
Narendra D LalwaniExec VP:Research & Dev/COOMindy LoweInvestor Relations
More Company Profile & Key Executives for ESPR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil